Anavex Life Sciences Corp (AVXL)

[Biostockclub]

As goes Oncology, so goes CNS?

This is an FDA approval for Lilly from today. I can’t bold but please note the language - the don’t call it “precision medicine” because mainstream doesn’t know those words but I like the way they get around it by describing the novel approach. Maybe, Anavex should try the same approach when describing our method for treating CNS arena indications
“No one ever went broke underestimating the intelligence of people.”

Just a thought. And that may go for the FDA as well...it gets them out of having to trial and review for separate indications if they can show with enough certainty that this approach works and saves time: kills several birds with one stone.

I’m pretty sure that’s why the last publication had further implications than simply the data of the trial on hand.

Here’s the LLY good news on 3 cancers:
(Source SA)


FDA approves Eli Lilly drug to treat three types of tumors

May 08, 2020 6:57 PM ETEli Lilly and Company (LLY)

Eli Lilly's (NYSE:LLY) Retevmo treatment is approved by the Food and Drug Administration for three types of tumors: non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancers.

The FDA calls Retevmo (selpercatinib) "the first therapy approved specifically for cancer patients with RET gene alterations," a mutation that occurs in ~2% of lung cancers and 10%-20% of papillary thyroid cancers.

Lilly's drug is part of a trend of treating cancer based on a patient's genetics rather than the location in the body where the disease originated.

Lilly will price the drug at $20,600 for 30 days of treatment, the head of the company's oncology division tells Reuters.


This third paragraph is in parallel to what we are doing.
“Lilly's drug is part of a trend of treating cancer based on a patient's genetics rather than the location in the body where the disease originated.”

So, if we can see in print, “Lilly’s drug approved for treating 3 types of tumors”,
we should not be surprised to read some day that “Anavex’s drug approved for treating 3 types of CNS diseases.”

FDA approves Eli Lilly drug to treat three types of tumors https://seekingalpha.com/news/3572368

As an aside, Dr. Missling mentioned at the ASM that we are doing a PDD trial with similar endpoints as Lilly so, “we are in good company”.

Perhaps, they have discussed the methodology as it applies to different medical branches and are on the same page?

GLTA,
Bio